{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:23:49Z","timestamp":1792419829155,"version":"4.5.0"},"reference-count":287,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"DOI":"10.1007\/s10565-025-10092-w","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T02:15:36Z","timestamp":1761876936000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["HypoxamiRs in pancreatic cancer: master regulators of the hypoxic tumor microenvironment"],"prefix":"10.1007","volume":"41","author":[{"given":"Pooria","family":"Salehi-Sangani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hosein","family":"Maharati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh","family":"Payami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Aliakbarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Abbaszadegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"issue":"1","key":"10092_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0311615","volume":"20","author":"E Abdo","year":"2025","unstructured":"Abdo E, et al. Effect of cytotoxic CD8+ T-cells secretory proteins on hypoxic pancreatic cancer cells. PLoS ONE. 2025;20(1):e0311615.","journal-title":"PLoS ONE"},{"issue":"2","key":"10092_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3892\/ijo.2014.2743","volume":"46","author":"M Abue","year":"2015","unstructured":"Abue M, et al. Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer. Int J Oncol. 2015;46(2):539\u201347.","journal-title":"Int J Oncol"},{"key":"10092_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9070845","author":"A Aita","year":"2021","unstructured":"Aita A, et al. Serum miRNA profiling for early PDAC diagnosis and prognosis: a retrospective study. Biomedicines. 2021. https:\/\/doi.org\/10.3390\/biomedicines9070845.","journal-title":"Biomedicines"},{"issue":"1","key":"10092_CR4","first-page":"28","volume":"3","author":"S Ali","year":"2010","unstructured":"Ali S, et al. Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer. Am J Transl Res. 2010;3(1):28\u201347.","journal-title":"Am J Transl Res"},{"issue":"3","key":"10092_CR5","first-page":"1251","volume":"5","author":"S Ali","year":"2015","unstructured":"Ali S, et al. Contribution of microRNAs in understanding the pancreatic tumor microenvironment involving cancer associated stellate and fibroblast cells. Am J Cancer Res. 2015;5(3):1251\u201364.","journal-title":"Am J Cancer Res"},{"key":"10092_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2020.07.024","volume":"491","author":"MK Ali","year":"2020","unstructured":"Ali MK, et al. Bacteria-derived minicells for cancer therapy. Cancer Lett. 2020;491:11\u201321.","journal-title":"Cancer Lett"},{"key":"10092_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1110743","volume":"14","author":"SM Al-Sisan","year":"2023","unstructured":"Al-Sisan SM, Zihlif MA, Hammad HM. Differential miRNA expression of hypoxic MCF7 and PANC-1 cells. Front Endocrinol (Lausanne). 2023;14:1110743.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10092_CR8","first-page":"1282","volume":"25","author":"A Angelin","year":"2017","unstructured":"Angelin A, et al. Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose. High-Lactate Environments Cell Metab. 2017;25(6):1282-1293.e7.","journal-title":"High-Lactate Environments Cell Metab"},{"issue":"3","key":"10092_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/00006676-200410000-00002","volume":"29","author":"MV Apte","year":"2004","unstructured":"Apte MV, et al. Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas. 2004;29(3):179\u201387.","journal-title":"Pancreas"},{"issue":"6","key":"10092_CR10","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1053\/j.gastro.2012.11.037","volume":"144","author":"MV Apte","year":"2013","unstructured":"Apte MV, et al. A starring role for stellate cells in the pancreatic cancer microenvironment. Gastroenterology. 2013;144(6):1210\u20139.","journal-title":"Gastroenterology"},{"issue":"1","key":"10092_CR11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.molonc.2015.09.006","volume":"10","author":"I Azimi","year":"2016","unstructured":"Azimi I, et al. Altered purinergic receptor-Ca2\u207a signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells. Mol Oncol. 2016;10(1):166\u201378.","journal-title":"Mol Oncol"},{"issue":"4","key":"10092_CR12","doi-asserted-by":"publisher","first-page":"6929","DOI":"10.18632\/oncotarget.14322","volume":"8","author":"J Bai","year":"2017","unstructured":"Bai J, et al. A retrospective study of NENs and miR-224 promotes apoptosis of BON-1 cells by targeting PCSK9 inhibition. Oncotarget. 2017;8(4):6929\u201339.","journal-title":"Oncotarget"},{"issue":"10","key":"10092_CR13","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1002\/eji.201343448","volume":"43","author":"M Balsamo","year":"2013","unstructured":"Balsamo M, et al. Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC. Eur J Immunol. 2013;43(10):2756\u201364.","journal-title":"Eur J Immunol"},{"issue":"12","key":"10092_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050165","volume":"7","author":"B Bao","year":"2012","unstructured":"Bao B, et al. Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment. PLoS ONE. 2012;7(12):e50165.","journal-title":"PLoS ONE"},{"issue":"6","key":"10092_CR15","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.yexcr.2005.11.028","volume":"312","author":"CE Barbieri","year":"2006","unstructured":"Barbieri CE, Pietenpol JA. p63 and epithelial biology. Exp Cell Res. 2006;312(6):695\u2013706.","journal-title":"Exp Cell Res"},{"issue":"24","key":"10092_CR16","doi-asserted-by":"publisher","first-page":"7433","DOI":"10.1158\/0008-5472.CAN-11-2104","volume":"71","author":"IB Barsoum","year":"2011","unstructured":"Barsoum IB, et al. Hypoxia induces escape from innate immunity in cancer cells via increased expression of ADAM10: role of nitric oxide. Cancer Res. 2011;71(24):7433\u201341.","journal-title":"Cancer Res"},{"issue":"49","key":"10092_CR17","doi-asserted-by":"publisher","first-page":"84928","DOI":"10.18632\/oncotarget.20863","volume":"8","author":"D Basso","year":"2017","unstructured":"Basso D, et al. PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis. Oncotarget. 2017;8(49):84928\u201344.","journal-title":"Oncotarget"},{"issue":"6","key":"10092_CR18","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ccr.2012.04.025","volume":"21","author":"LJ Bayne","year":"2012","unstructured":"Bayne LJ, et al. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell. 2012;21(6):822\u201335.","journal-title":"Cancer Cell"},{"issue":"6","key":"10092_CR19","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","volume":"38","author":"AS Bear","year":"2020","unstructured":"Bear AS, Vonderheide RH, O\u2019Hara MH. Challenges and opportunities for pancreatic cancer immunotherapy. Cancer Cell. 2020;38(6):788\u2013802.","journal-title":"Cancer Cell"},{"issue":"26","key":"10092_CR20","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1038\/onc.2011.37","volume":"30","author":"EL Bell","year":"2011","unstructured":"Bell EL, et al. Sirt3 suppresses hypoxia inducible factor 1\u03b1 and tumor growth by inhibiting mitochondrial ROS production. Oncogene. 2011;30(26):2986\u201396.","journal-title":"Oncogene"},{"issue":"7","key":"10092_CR21","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1182\/blood-2007-08-106203","volume":"111","author":"G Bernardini","year":"2008","unstructured":"Bernardini G, et al. CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets. Blood. 2008;111(7):3626\u201334.","journal-title":"Blood"},{"issue":"1","key":"10092_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00048.2019","volume":"101","author":"G Biffi","year":"2021","unstructured":"Biffi G, Tuveson DA. Diversity and biology of cancer-associated fibroblasts. Physiol Rev. 2021;101(1):147\u201376.","journal-title":"Physiol Rev"},{"issue":"7","key":"10092_CR23","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/carcin\/bgm052","volume":"28","author":"C Blanco-Aparicio","year":"2007","unstructured":"Blanco-Aparicio C, et al. PTEN, more than the AKT pathway. Carcinogenesis. 2007;28(7):1379\u201386.","journal-title":"Carcinogenesis"},{"issue":"1","key":"10092_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0378-1119(02)00928-9","volume":"298","author":"A Bratt","year":"2002","unstructured":"Bratt A, et al. Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains. Gene. 2002;298(1):69\u201377.","journal-title":"Gene"},{"issue":"3","key":"10092_CR25","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"10092_CR26","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1128\/MCB.01276-10","volume":"31","author":"U Bruning","year":"2011","unstructured":"Bruning U, et al. MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia. Mol Cell Biol. 2011;31(19):4087\u201396.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"10092_CR27","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.3892\/or.2016.4709","volume":"35","author":"L Cao","year":"2016","unstructured":"Cao L, et al. Curcumin inhibits hypoxia-induced epithelial-mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway. Oncol Rep. 2016;35(6):3728\u201334.","journal-title":"Oncol Rep"},{"issue":"5","key":"10092_CR28","doi-asserted-by":"publisher","first-page":"7120","DOI":"10.18632\/aging.202569","volume":"13","author":"W Cao","year":"2021","unstructured":"Cao W, et al. Hypoxic pancreatic stellate cell-derived exosomal mirnas promote proliferation and invasion of pancreatic cancer through the PTEN\/AKT pathway. Aging (Albany NY). 2021;13(5):7120\u201332.","journal-title":"Aging (Albany NY)"},{"issue":"6801","key":"10092_CR29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/35025220","volume":"407","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407(6801):249\u201357.","journal-title":"Nature"},{"issue":"14","key":"10092_CR30","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1038\/onc.2013.121","volume":"33","author":"A Casazza","year":"2014","unstructured":"Casazza A, et al. Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment. Oncogene. 2014;33(14):1743\u201354.","journal-title":"Oncogene"},{"key":"10092_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12051119","author":"S Cassim","year":"2020","unstructured":"Cassim S, et al. Warburg and beyond: the power of mitochondrial metabolism to collaborate or replace fermentative glycolysis in cancer. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12051119.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10092_CR32","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.cell.2011.09.028","volume":"147","author":"M Cesana","year":"2011","unstructured":"Cesana M, et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 2011;147(2):358\u201369.","journal-title":"Cell"},{"issue":"4","key":"10092_CR33","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s10565-021-09597-x","volume":"38","author":"J Chang","year":"2022","unstructured":"Chang J, et al. microRNA-21-5p from M2 macrophage-derived extracellular vesicles promotes the differentiation and activity of pancreatic cancer stem cells by mediating KLF3. Cell Biol Toxicol. 2022;38(4):577\u201390.","journal-title":"Cell Biol Toxicol"},{"issue":"8","key":"10092_CR34","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41580-020-0243-y","volume":"21","author":"LL Chen","year":"2020","unstructured":"Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21(8):475\u201390.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"32","key":"10092_CR35","doi-asserted-by":"publisher","first-page":"32701","DOI":"10.18632\/oncotarget.4702","volume":"6","author":"D Chen","year":"2015","unstructured":"Chen D, et al. Mir-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1\u03b1-TWIST signaling axis in breast cancer. Oncotarget. 2015;6(32):32701\u201312.","journal-title":"Oncotarget"},{"issue":"6","key":"10092_CR36","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00018-017-2666-y","volume":"75","author":"Y Chen","year":"2018","unstructured":"Chen Y, et al. A double dealing tale of p63: an oncogene or a tumor suppressor. Cell Mol Life Sci. 2018;75(6):965\u201373.","journal-title":"Cell Mol Life Sci"},{"key":"10092_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.canlet.2018.12.017","volume":"446","author":"S Chen","year":"2019","unstructured":"Chen S, et al. Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8. Cancer Lett. 2019a;446:49\u201361.","journal-title":"Cancer Lett"},{"issue":"4","key":"10092_CR38","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cell.2019.01.025","volume":"176","author":"S Chen","year":"2019","unstructured":"Chen S, et al. Widespread and functional RNA circularization in localized prostate cancer. Cell. 2019b;176(4):831-843.e22.","journal-title":"Cell"},{"issue":"3","key":"10092_CR39","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.7150\/ijbs.67675","volume":"18","author":"K Chen","year":"2022","unstructured":"Chen K, et al. Hypoxic pancreatic cancer derived exosomal miR-30b-5p promotes tumor angiogenesis by inhibiting GJA1 expression. Int J Biol Sci. 2022;18(3):1220\u201337.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"10092_CR40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s10565-024-09863-8","volume":"40","author":"J Chen","year":"2024","unstructured":"Chen J, et al. Mkln1-AS promotes pancreatic cancer progression as a crucial downstream mediator of HIF-1\u03b1 through miR-185-5p\/TEAD1 pathway. Cell Biol Toxicol. 2024;40(1):30.","journal-title":"Cell Biol Toxicol"},{"issue":"8","key":"10092_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023752","volume":"6","author":"ZX Cheng","year":"2011","unstructured":"Cheng ZX, et al. Nuclear factor-\u03baB-dependent epithelial to mesenchymal transition induced by HIF-1\u03b1 activation in pancreatic cancer cells under hypoxic conditions. PLoS ONE. 2011;6(8):e23752.","journal-title":"PLoS ONE"},{"key":"10092_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113008","author":"Q Cheng","year":"2021","unstructured":"Cheng Q, et al. FGFR1 overexpression induces cancer cell stemness and enhanced Akt\/Erk-ER signaling to promote palbociclib resistance in luminal A breast cancer cells. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10113008.","journal-title":"Cells"},{"issue":"9","key":"10092_CR43","doi-asserted-by":"publisher","first-page":"740827","DOI":"10.3389\/fcell.2021.740827","volume":"23","author":"JN Cheng","year":"2021","unstructured":"Cheng JN, Yuan YX, Zhu B, Jia Q. Myeloid-derived suppressor cells: a multifaceted accomplice in tumor progression. Front Cell Develop Biol. 2021;23(9):740827.","journal-title":"Front Cell Develop Biol"},{"key":"10092_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/cells8091015","author":"Y Chi","year":"2019","unstructured":"Chi Y, et al. Long non-coding RNA in the pathogenesis of cancers. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8091015.","journal-title":"Cells"},{"key":"10092_CR45","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.biomaterials.2017.05.026","volume":"139","author":"JU Choi","year":"2017","unstructured":"Choi JU, et al. A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathway. Biomaterials. 2017;139:56\u201366.","journal-title":"Biomaterials"},{"issue":"39","key":"10092_CR46","doi-asserted-by":"publisher","first-page":"13944","DOI":"10.1073\/pnas.0506654102","volume":"102","author":"A Cimmino","year":"2005","unstructured":"Cimmino A, et al. MiR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005;102(39):13944\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10092_CR47","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1038\/ajg.2014.331","volume":"109","author":"GA Cote","year":"2014","unstructured":"Cote GA, et al. A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile. Am J Gastroenterol. 2014;109(12):1942\u201352.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10092_CR48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12964-019-0502-8","volume":"18","author":"W Dai","year":"2020","unstructured":"Dai W, et al. FOXE1 represses cell proliferation and Warburg effect by inhibiting HK2 in colorectal cancer. Cell Commun Signal. 2020;18(1):7.","journal-title":"Cell Commun Signal"},{"issue":"4","key":"10092_CR49","first-page":"1387","volume":"98","author":"N de Paulsen","year":"2001","unstructured":"de Paulsen N. Role of transforming growth factor-alpha in von Hippel-Lindau (VHL)(-\/-) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis. Proc Natl Acad Sci U S A. 2001;98(4):1387\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10092_CR50","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/mc.23668","volume":"63","author":"K Deng","year":"2024","unstructured":"Deng K, et al. Cancer-associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF-1\u03b1\/miR-21 axis under hypoxic conditions in pancreatic cancer. Mol Carcinog. 2024;63(3):524\u201337.","journal-title":"Mol Carcinog"},{"key":"10092_CR51","first-page":"491","volume":"17","author":"ZV Diaz-Riascos","year":"2019","unstructured":"Diaz-Riascos ZV, et al. Expression and role of MicroRNAs from the miR-200 family in the tumor formation and metastatic propensity of pancreatic cancer. Mol Ther. 2019;17:491\u2013503.","journal-title":"Mol Ther"},{"key":"10092_CR52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ceb.2016.06.002","volume":"43","author":"M Diepenbruck","year":"2016","unstructured":"Diepenbruck M, Christofori G. Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe? Curr Opin Cell Biol. 2016;43:7\u201313.","journal-title":"Curr Opin Cell Biol"},{"issue":"17","key":"10092_CR53","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1091\/mbc.e14-01-0044","volume":"25","author":"R Du","year":"2014","unstructured":"Du R, et al. Hypoxia-induced Bmi1 promotes renal tubular epithelial cell-mesenchymal transition and renal fibrosis via PI3K\/Akt signal. Mol Biol Cell. 2014;25(17):2650\u20139.","journal-title":"Mol Biol Cell"},{"issue":"2","key":"10092_CR54","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/gutjnl-2011-301220","volume":"61","author":"M Erkan","year":"2012","unstructured":"Erkan M, et al. StellaTUM: current consensus and discussion on pancreatic stellate cell research. Gut. 2012;61(2):172\u20138.","journal-title":"Gut"},{"key":"10092_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154913","volume":"251","author":"A Fanoodi","year":"2023","unstructured":"Fanoodi A, et al. Micrornas as the critical regulators of tumor angiogenesis in liver cancer. Pathol Res Pract. 2023;251:154913.","journal-title":"Pathol Res Pract"},{"issue":"3","key":"10092_CR56","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.blre.2005.10.001","volume":"20","author":"SS Farag","year":"2006","unstructured":"Farag SS, Caligiuri MA. Human natural killer cell development and biology. Blood Rev. 2006;20(3):123\u201337.","journal-title":"Blood Rev"},{"issue":"1","key":"10092_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trim.2008.01.004","volume":"19","author":"JE Fildes","year":"2008","unstructured":"Fildes JE, Yonan N, Leonard CT. Natural killer cells and lung transplantation, roles in rejection, infection, and tolerance. Transpl Immunol. 2008;19(1):1\u201311.","journal-title":"Transpl Immunol"},{"key":"10092_CR58","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","volume":"236","author":"LM Francisco","year":"2010","unstructured":"Francisco LM, Sage PT, Sharpe AH. The PD-1 pathway in tolerance and autoimmunity. Immunol Rev. 2010;236:219\u201342.","journal-title":"Immunol Rev"},{"issue":"7","key":"10092_CR59","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1053\/j.gastro.2022.02.024","volume":"162","author":"CJ Garcia Garcia","year":"2022","unstructured":"Garcia Garcia CJ, et al. Stromal HIF2 regulates immune suppression in the pancreatic cancer microenvironment. Gastroenterology. 2022;162(7):2018\u201331.","journal-title":"Gastroenterology"},{"key":"10092_CR60","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1146\/annurev.med.59.053006.104707","volume":"60","author":"R Garzon","year":"2009","unstructured":"Garzon R, Calin GA, Croce CM. Micrornas in cancer. Annu Rev Med. 2009;60:167\u201379.","journal-title":"Annu Rev Med"},{"issue":"1","key":"10092_CR61","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41467-018-08076-y","volume":"10","author":"Y Ge","year":"2019","unstructured":"Ge Y, et al. The splicing factor RBM25 controls MYC activity in acute myeloid leukemia. Nat Commun. 2019;10(1):172.","journal-title":"Nat Commun"},{"issue":"8","key":"10092_CR62","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1089\/ars.2013.5639","volume":"21","author":"HE Gee","year":"2014","unstructured":"Gee HE, et al. HypoxamiRs and cancer: from biology to targeted therapy. Antioxid Redox Signal. 2014;21(8):1220\u201338.","journal-title":"Antioxid Redox Signal"},{"issue":"20","key":"10092_CR63","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1038\/onc.2014.200","volume":"34","author":"L G\u00f3mez-Maldonado","year":"2015","unstructured":"G\u00f3mez-Maldonado L, et al. EFNA3 long noncoding RNAs induced by hypoxia promote metastatic dissemination. Oncogene. 2015;34(20):2609\u201320.","journal-title":"Oncogene"},{"issue":"16","key":"10092_CR64","doi-asserted-by":"publisher","first-page":"22650","DOI":"10.18632\/oncotarget.7998","volume":"7","author":"N Gomez-Roman","year":"2016","unstructured":"Gomez-Roman N, et al. Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer. Oncotarget. 2016;7(16):22650.","journal-title":"Oncotarget"},{"issue":"46","key":"10092_CR65","doi-asserted-by":"publisher","first-page":"7956","DOI":"10.3748\/wjg.v27.i46.7956","volume":"27","author":"MR Goulart","year":"2021","unstructured":"Goulart MR, et al. T cells in pancreatic cancer stroma. World J Gastroenterol. 2021;27(46):7956\u201368.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10092_CR66","doi-asserted-by":"publisher","first-page":"8308","DOI":"10.1074\/jbc.M110.197301","volume":"286","author":"D Grasso","year":"2011","unstructured":"Grasso D, et al. Zymophagy, a novel selective autophagy pathway mediated by VMP1-USP9x-p62, prevents pancreatic cell death. J Biol Chem. 2011;286(10):8308\u201324.","journal-title":"J Biol Chem"},{"issue":"8","key":"10092_CR67","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1089\/ars.2014.6083","volume":"21","author":"S Greco","year":"2014","unstructured":"Greco S, Martelli F. Micrornas in hypoxia response. Antioxid Redox Signal. 2014;21(8):1164\u20136.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"10092_CR68","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1186\/s12864-021-07880-z","volume":"22","author":"H Gu","year":"2021","unstructured":"Gu H, et al. Circ_0038718 promotes colon cancer cell malignant progression via the miR-195-5p\/Axin2 signaling axis and also effect Wnt\/\u03b2-catenin signal pathway. BMC Genomics. 2021;22(1):768.","journal-title":"BMC Genomics"},{"issue":"3","key":"10092_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/cells5030034","volume":"5","author":"F Guerra","year":"2016","unstructured":"Guerra F, Bucci C. Multiple roles of the small GTPase Rab7. Cells. 2016;5(3):34.","journal-title":"Cells"},{"issue":"9","key":"10092_CR70","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1158\/0008-5472.CAN-10-4058","volume":"71","author":"P Gulhati","year":"2011","unstructured":"Gulhati P, et al. mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res. 2011;71(9):3246\u201356.","journal-title":"Cancer Res"},{"issue":"1","key":"10092_CR71","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bpa.12545","volume":"28","author":"F Guo","year":"2018","unstructured":"Guo F, et al. Autophagy in neurodegenerative diseases: pathogenesis and therapy. Brain Pathol. 2018;28(1):3\u201313.","journal-title":"Brain Pathol"},{"key":"10092_CR72","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.omtn.2020.08.021","volume":"22","author":"Z Guo","year":"2020","unstructured":"Guo Z, et al. Hypoxic tumor-derived exosomal long noncoding RNA UCA1 promotes angiogenesis via miR-96-5p\/AMOTL2 in pancreatic cancer. Mol Ther Nucleic Acids. 2020;22:179\u201395.","journal-title":"Mol Ther Nucleic Acids"},{"key":"10092_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111407","volume":"127","author":"Y Guo","year":"2024","unstructured":"Guo Y, et al. Pancreatic cancer stem cell-derived exosomal miR-210 mediates macrophage M2 polarization and promotes gemcitabine resistance by targeting FGFRL1. Int Immunopharmacol. 2024;127:111407.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"10092_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2023.05.014","volume":"11","author":"S Hao","year":"2024","unstructured":"Hao S, et al. Long non-coding RNA BANCR promotes pancreatic cancer lymphangiogenesis and lymphatic metastasis by regulating the HIF-1\u03b1\/VEGF-C\/VEGFR-3 pathway via miR-143-5p. Genes Dis. 2024;11(4):101015.","journal-title":"Genes Dis"},{"issue":"1","key":"10092_CR75","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrc704","volume":"2","author":"AL Harris","year":"2002","unstructured":"Harris AL. Hypoxia\u2013a key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2(1):38\u201347.","journal-title":"Nat Rev Cancer"},{"issue":"7043","key":"10092_CR76","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nature03552","volume":"435","author":"L He","year":"2005","unstructured":"He L, et al. A microRNA polycistron as a potential human oncogene. Nature. 2005;435(7043):828\u201333.","journal-title":"Nature"},{"issue":"3","key":"10092_CR77","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41419-022-04677-0","volume":"13","author":"Z He","year":"2022","unstructured":"He Z, et al. Autophagy-associated circRNA circATG7 facilitates autophagy and promotes pancreatic cancer progression. Cell Death Dis. 2022;13(3):233.","journal-title":"Cell Death Dis"},{"key":"10092_CR78","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neulet.2016.04.034","volume":"622","author":"YW Hu","year":"2016","unstructured":"Hu YW, et al. MicroRNA-210 promotes sensory axon regeneration of adult mice in vivo and in vitro. Neurosci Lett. 2016;622:61\u20136.","journal-title":"Neurosci Lett"},{"issue":"1","key":"10092_CR79","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/1097-0215(200102)9999:9999<::AID-IJC1165>3.0.CO;2-G","volume":"92","author":"RP Huang","year":"2001","unstructured":"Huang RP, et al. Connexin 43 (cx43) enhances chemotherapy-induced apoptosis in human glioblastoma cells. Int J Cancer. 2001;92(1):130\u20138.","journal-title":"Int J Cancer"},{"issue":"3","key":"10092_CR80","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1158\/0008-5472.CAN-07-5714","volume":"68","author":"RF Hwang","year":"2008","unstructured":"Hwang RF, et al. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 2008;68(3):918\u201326.","journal-title":"Cancer Res"},{"key":"10092_CR81","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.coi.2015.11.001","volume":"38","author":"A Iannello","year":"2016","unstructured":"Iannello A, et al. Immunosurveillance and immunotherapy of tumors by innate immune cells. Curr Opin Immunol. 2016;38:52\u20138.","journal-title":"Curr Opin Immunol"},{"issue":"14","key":"10092_CR82","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1158\/1078-0432.CCR-16-1762","volume":"23","author":"AA Ibrahim","year":"2017","unstructured":"Ibrahim AA, et al. Hypoxia causes downregulation of Dicer in hepatocellular carcinoma, which is required for upregulation of Hypoxia-inducible factor 1\u03b1 and epithelial-mesenchymal transition. Clin Cancer Res. 2017;23(14):3896\u2013905.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10092_CR83","doi-asserted-by":"publisher","first-page":"254","DOI":"10.2174\/18715206MTA53ODY5y","volume":"21","author":"K Ilkhani","year":"2021","unstructured":"Ilkhani K, et al. The engaged role of tumor microenvironment in cancer metabolism: focusing on cancer-associated fibroblast and exosome mediators. Anticancer Agents Med Chem. 2021;21(2):254\u201366.","journal-title":"Anticancer Agents Med Chem"},{"issue":"34","key":"10092_CR84","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1200\/JCO.2009.24.0317","volume":"27","author":"MV Iorio","year":"2009","unstructured":"Iorio MV, Croce CM. Micrornas in cancer: small molecules with a huge impact. J Clin Oncol. 2009;27(34):5848\u201356.","journal-title":"J Clin Oncol"},{"issue":"8","key":"10092_CR85","first-page":"1309","volume":"3","author":"J Itakura","year":"1997","unstructured":"Itakura J, et al. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Clin Cancer Res. 1997;3(8):1309\u201316.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10092_CR86","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41417-025-00900-0","volume":"32","author":"Y Jin","year":"2025","unstructured":"Jin Y, et al. The role of LncRNA-MANCR induced by HIF-1\u03b1 drive the malignant progression of pancreatic cancer by targeting miRNA-494\/SIRT1 signaling axis under hypoxic conditions. Cancer Gene Ther. 2025;32(6):633\u201348.","journal-title":"Cancer Gene Ther"},{"issue":"10","key":"10092_CR87","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1002\/ijc.30291","volume":"139","author":"JS Johansen","year":"2016","unstructured":"Johansen JS, et al. The potential diagnostic value of serum microRNA signature in patients with pancreatic cancer. Int J Cancer. 2016;139(10):2312\u201324.","journal-title":"Int J Cancer"},{"issue":"5","key":"10092_CR88","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cell.2005.01.014","volume":"120","author":"SM Johnson","year":"2005","unstructured":"Johnson SM, et al. RAS is regulated by the let-7 microRNA family. Cell. 2005;120(5):635\u201347.","journal-title":"Cell"},{"issue":"7","key":"10092_CR89","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1158\/1078-0432.CCR-16-2318","volume":"23","author":"BA Johnson 3rd","year":"2017","unstructured":"Johnson BA 3rd, et al. Strategies for increasing pancreatic tumor immunogenicity. Clin Cancer Res. 2017;23(7):1656\u201369.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10092_CR90","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.canlet.2015.01.010","volume":"359","author":"JV Joseph","year":"2015","unstructured":"Joseph JV, et al. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1\u03b1-ZEB1 axis. Cancer Lett. 2015;359(1):107\u201316.","journal-title":"Cancer Lett"},{"issue":"2","key":"10092_CR91","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/bjc.2012.546","volume":"108","author":"T Kawaguchi","year":"2013","unstructured":"Kawaguchi T, et al. Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer. Br J Cancer. 2013;108(2):361\u20139.","journal-title":"Br J Cancer"},{"issue":"1","key":"10092_CR92","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1038\/s41598-021-82266-5","volume":"11","author":"IA Khan","year":"2021","unstructured":"Khan IA, et al. Panel of serum miRNAs as potential non-invasive biomarkers for pancreatic ductal adenocarcinoma. Sci Rep. 2021;11(1):2824.","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"10092_CR93","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11010-013-1872-7","volume":"387","author":"JS Kim","year":"2014","unstructured":"Kim JS, et al. Microrna-205 suppresses the oral carcinoma oncogenic activity via down-regulation of Axin-2 in KB human oral cancer cell. Mol Cell Biochem. 2014;387(1\u20132):71\u20139.","journal-title":"Mol Cell Biochem"},{"issue":"22","key":"10092_CR94","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1200\/JCO.2010.28.1386","volume":"28","author":"HL Kindler","year":"2010","unstructured":"Kindler HL, et al. Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303). J Clin Oncol. 2010;28(22):3617\u201322.","journal-title":"J Clin Oncol"},{"key":"10092_CR95","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1196\/annals.1397.013","volume":"1095","author":"M Koda","year":"2007","unstructured":"Koda M, et al. Expression of leptin, leptin receptor, and hypoxia-inducible factor 1 alpha in human endometrial cancer. Ann N Y Acad Sci. 2007;1095:90\u20138.","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10092_CR96","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1128\/MCB.26.6.2019-2028.2006","volume":"26","author":"X Kong","year":"2006","unstructured":"Kong X, et al. Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha. Mol Cell Biol. 2006;26(6):2019\u201328.","journal-title":"Mol Cell Biol"},{"key":"10092_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2013.00246","volume":"4","author":"B Kong","year":"2013","unstructured":"Kong B, et al. Overview on how oncogenic Kras promotes pancreatic carcinogenesis by inducing low intracellular ROS levels. Front Physiol. 2013;4:246.","journal-title":"Front Physiol"},{"key":"10092_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13184711","author":"J Koo","year":"2021","unstructured":"Koo J, et al. Whole-brain radiotherapy vs. localized radiotherapy after resection of brain metastases in the era of targeted therapy: a retrospective study. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13184711.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10092_CR99","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12(8):599\u2013620.","journal-title":"Protein Cell"},{"issue":"2","key":"10092_CR100","first-page":"81","volume":"1756","author":"O Kranenburg","year":"2005","unstructured":"Kranenburg O. The KRAS oncogene: past, present, and future. Biochim Biophys Acta. 2005;1756(2):81\u20132.","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"10092_CR101","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS, et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675\u201391.","journal-title":"Nat Rev Genet"},{"issue":"2","key":"10092_CR102","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/onc.2013.530","volume":"34","author":"B K\u00fchnemuth","year":"2015","unstructured":"K\u00fchnemuth B, et al. CUX1 modulates polarization of tumor-associated macrophages by antagonizing NF-\u03baB signaling. Oncogene. 2015;34(2):177\u201387.","journal-title":"Oncogene"},{"issue":"1","key":"10092_CR103","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0092-8674(04)00261-2","volume":"117","author":"YS Lee","year":"2004","unstructured":"Lee YS, et al. Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA\/miRNA silencing pathways. Cell. 2004;117(1):69\u201381.","journal-title":"Cell"},{"key":"10092_CR104","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jconrel.2019.10.007","volume":"313","author":"SWL Lee","year":"2019","unstructured":"Lee SWL, et al. Microrna delivery through nanoparticles. J Control Release. 2019;313:80\u201395.","journal-title":"J Control Release"},{"issue":"12","key":"10092_CR105","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3109\/02713683.2016.1145234","volume":"41","author":"R Li","year":"2016","unstructured":"Li R, Du J, Chang Y. Role of autophagy in hypoxia-induced angiogenesis of RF\/6A cells in vitro. Curr Eye Res. 2016a;41(12):1566\u201370.","journal-title":"Curr Eye Res"},{"issue":"5","key":"10092_CR106","doi-asserted-by":"publisher","first-page":"6000","DOI":"10.18632\/oncotarget.6830","volume":"7","author":"X Li","year":"2016","unstructured":"Li X, et al. Hypoxia-induced lncRNA-NUTF2P3-001 contributes to tumorigenesis of pancreatic cancer by derepressing the miR-3923\/KRAS pathway. Oncotarget. 2016b;7(5):6000\u201314.","journal-title":"Oncotarget"},{"issue":"11","key":"10092_CR107","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1111\/jcmm.13202","volume":"21","author":"W Li","year":"2017","unstructured":"Li W, et al. HIF-2\u03b1 regulates non-canonical glutamine metabolism via activation of PI3K\/mTORC2 pathway in human pancreatic ductal adenocarcinoma. J Cell Mol Med. 2017a;21(11):2896\u2013908.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10092_CR108","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12943-017-0738-0","volume":"16","author":"H Li","year":"2017","unstructured":"Li H, et al. Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer. Mol Cancer. 2017b;16(1):169.","journal-title":"Mol Cancer"},{"issue":"5","key":"10092_CR109","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s43018-020-0061-3","volume":"1","author":"T Li","year":"2020","unstructured":"Li T, et al. C-Rel is a myeloid checkpoint for cancer immunotherapy. Nat Cancer. 2020a;1(5):507\u201317.","journal-title":"Nat Cancer"},{"key":"10092_CR110","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.canlet.2020.06.009","volume":"490","author":"M Li","year":"2020","unstructured":"Li M, et al. Pancreatic stellate cells derived exosomal miR-5703 promotes pancreatic cancer by downregulating CMTM4 and activating PI3K\/Akt pathway. Cancer Lett. 2020b;490:20\u201330.","journal-title":"Cancer Lett"},{"issue":"22","key":"10092_CR111","doi-asserted-by":"publisher","first-page":"12723","DOI":"10.1093\/nar\/gkac1063","volume":"50","author":"F Li","year":"2022","unstructured":"Li F, et al. TEAD1 regulates cell proliferation through a pocket-independent transcription repression mechanism. Nucleic Acids Res. 2022a;50(22):12723\u201338.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10092_CR112","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/clinchem\/hvab254","volume":"68","author":"P Li","year":"2022","unstructured":"Li P, et al. Circular RNA sequencing reveals serum exosome circular RNA panel for high-grade astrocytoma diagnosis. Clin Chem. 2022b;68(2):332\u201343.","journal-title":"Clin Chem"},{"issue":"13","key":"10092_CR113","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.2174\/1386207326666230314112238","volume":"26","author":"L Li","year":"2023","unstructured":"Li L, et al. Hypoxia-induced long non-coding RNA LSAMP-AS1 regulates ceRNA network to predict prognosis for pancreatic cancer. Comb Chem High Throughput Screen. 2023;26(13):2358\u201371.","journal-title":"Comb Chem High Throughput Screen"},{"key":"10092_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110799","volume":"132","author":"S Liang","year":"2020","unstructured":"Liang S, et al. Microrna-based autophagy inhibition as targeted therapy in pancreatic cancer. Biomed Pharmacother. 2020a;132:110799.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10092_CR115","first-page":"1548","volume":"10","author":"L Liang","year":"2020","unstructured":"Liang L, et al. Slc25a18 has prognostic value in colorectal cancer and represses Warburg effect and cell proliferation via Wnt signaling. Am J Cancer Res. 2020b;10(5):1548\u201367.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"10092_CR116","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1053\/j.gastro.2021.09.044","volume":"162","author":"X Liang","year":"2022","unstructured":"Liang X, et al. An enhancer-driven stem cell-like program mediated by SOX9 blocks intestinal differentiation in colorectal cancer. Gastroenterology. 2022;162(1):209\u201322.","journal-title":"Gastroenterology"},{"issue":"1","key":"10092_CR117","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-021-00570-z","volume":"11","author":"SM Lim","year":"2021","unstructured":"Lim SM, Mohamad Hanif EA, Chin SF. Is targeting autophagy mechanism in cancer a good approach? The possible double-edge sword effect. Cell Biosci. 2021;11(1):56.","journal-title":"Cell Biosci"},{"issue":"11","key":"10092_CR118","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142656","volume":"10","author":"YM Lin","year":"2015","unstructured":"Lin YM, et al. High PD-L1 expression correlates with metastasis and poor prognosis in oral squamous cell carcinoma. PLoS ONE. 2015;10(11):e0142656.","journal-title":"PLoS ONE"},{"key":"10092_CR119","doi-asserted-by":"publisher","first-page":"13867","DOI":"10.1038\/ncomms13867","volume":"7","author":"CW Lin","year":"2016","unstructured":"Lin CW, et al. Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1\u03b1\/HDAC1\/Slug axis. Nat Commun. 2016;7:13867.","journal-title":"Nat Commun"},{"issue":"1","key":"10092_CR120","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13045-022-01348-7","volume":"15","author":"J Lin","year":"2022","unstructured":"Lin J, et al. Hypoxia-induced exosomal circPDK1 promotes pancreatic cancer glycolysis via c-myc activation by modulating miR-628-3p\/BPTF axis and degrading BIN1. J Hematol Oncol. 2022;15(1):128.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"10092_CR121","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1007\/s12094-021-02599-5","volume":"23","author":"A Liu","year":"2021","unstructured":"Liu A, Xu J. Circ_03955 promotes pancreatic cancer tumorigenesis and warburg effect by targeting the miR-3662\/HIF-1\u03b1 axis. Clin Transl Oncol. 2021;23(9):1905\u201314.","journal-title":"Clin Transl Oncol"},{"issue":"6","key":"10092_CR122","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1158\/1535-7163.MCT-10-1010","volume":"10","author":"Q Liu","year":"2011","unstructured":"Liu Q, et al. Hypoxia induces genomic DNA demethylation through the activation of HIF-1\u03b1 and transcriptional upregulation of MAT2A in hepatoma cells. Mol Cancer Ther. 2011;10(6):1113\u201323.","journal-title":"Mol Cancer Ther"},{"issue":"17","key":"10092_CR123","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.2174\/13816128112092395","volume":"18","author":"H Liu","year":"2012","unstructured":"Liu H, et al. Therapeutic potential of perineural invasion, hypoxia and desmoplasia in pancreatic cancer. Curr Pharm des. 2012a;18(17):2395\u2013403.","journal-title":"Curr Pharm des"},{"issue":"3","key":"10092_CR124","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/ijc.26422","volume":"131","author":"J Liu","year":"2012","unstructured":"Liu J, et al. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. Int J Cancer. 2012b;131(3):683\u201391.","journal-title":"Int J Cancer"},{"issue":"3","key":"10092_CR125","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1373\/clinchem.2011.172767","volume":"58","author":"R Liu","year":"2012","unstructured":"Liu R, et al. Serum microrna expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem. 2012c;58(3):610\u20138.","journal-title":"Clin Chem"},{"issue":"5","key":"10092_CR126","first-page":"2149","volume":"26","author":"W Liu","year":"2021","unstructured":"Liu W, et al. Microrna-204-3p inhibits metastasis of pancreatic cancer via downregulating MGAT1. J Buon. 2021a;26(5):2149\u201356.","journal-title":"J Buon"},{"issue":"2","key":"10092_CR127","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/MPA.0000000000001747","volume":"50","author":"YF Liu","year":"2021","unstructured":"Liu YF, et al. PVT1 knockdown inhibits autophagy and improves Gemcitabine sensitivity by regulating the MiR-143\/HIF-1\u03b1\/VMP1 axis in pancreatic cancer. Pancreas. 2021b;50(2):227\u201334.","journal-title":"Pancreas"},{"issue":"2","key":"10092_CR128","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00280-021-04289-z","volume":"88","author":"A Liu","year":"2021","unstructured":"Liu A, et al. Mirna-3662 reverses the gemcitabine resistance in pancreatic cancer through regulating the tumor metabolism. Cancer Chemother Pharmacol. 2021c;88(2):343\u201357.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"10092_CR129","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41420-024-02035-x","volume":"10","author":"X Liu","year":"2024","unstructured":"Liu X, et al. Hypoxia-induced epigenetic regulation of miR-485-3p promotes stemness and chemoresistance in pancreatic ductal adenocarcinoma via SLC7A11-mediated ferroptosis. Cell Death Discov. 2024;10(1):262.","journal-title":"Cell Death Discov"},{"issue":"8","key":"10092_CR130","doi-asserted-by":"publisher","first-page":"919","DOI":"10.4161\/cc.6.8.4133","volume":"6","author":"T L\u00f6fstedt","year":"2007","unstructured":"L\u00f6fstedt T, et al. Hypoxia inducible factor-2alpha in cancer. Cell Cycle. 2007;6(8):919\u201326.","journal-title":"Cell Cycle"},{"issue":"24","key":"10092_CR131","doi-asserted-by":"publisher","first-page":"5928","DOI":"10.1158\/1078-0432.CCR-10-1360","volume":"16","author":"X Lu","year":"2010","unstructured":"Lu X, Kang Y. Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin Cancer Res. 2010;16(24):5928\u201335.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10092_CR132","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1242\/bio.021774","volume":"6","author":"Y Lu","year":"2017","unstructured":"Lu Y, et al. Mir-142 modulates human pancreatic cancer proliferation and invasion by targeting hypoxia-inducible factor 1 (HIF-1\u03b1) in the tumor microenvironments. Biol Open. 2017;6(2):252\u20139.","journal-title":"Biol Open"},{"issue":"1","key":"10092_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MPA.0000000000000686","volume":"46","author":"A Lugea","year":"2017","unstructured":"Lugea A, Waldron RT. Exosome-mediated intercellular communication between Stellate cells and cancer cells in Pancreatic ductal adenocarcinoma. Pancreas. 2017;46(1):1\u20134.","journal-title":"Pancreas"},{"issue":"5","key":"10092_CR134","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.cell.2011.03.054","volume":"145","author":"W Luo","year":"2011","unstructured":"Luo W, et al. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell. 2011;145(5):732\u201344.","journal-title":"Cell"},{"issue":"1","key":"10092_CR135","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.yexcr.2018.05.013","volume":"369","author":"G Luo","year":"2018","unstructured":"Luo G, et al. Mir-301a plays a pivotal role in hypoxia-induced gemcitabine resistance in pancreatic cancer. Exp Cell Res. 2018;369(1):120\u20138.","journal-title":"Exp Cell Res"},{"issue":"2","key":"10092_CR136","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.jss.2013.04.061","volume":"184","author":"TA Mace","year":"2013","unstructured":"Mace TA, et al. Hypoxia induces the overexpression of microRNA-21 in pancreatic cancer cells. J Surg Res. 2013;184(2):855\u201360.","journal-title":"J Surg Res"},{"issue":"4","key":"10092_CR137","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ccr.2010.02.030","volume":"17","author":"P Mak","year":"2010","unstructured":"Mak P, et al. ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading. Cancer Cell. 2010;17(4):319\u201332.","journal-title":"Cancer Cell"},{"issue":"5","key":"10092_CR138","doi-asserted-by":"publisher","first-page":"9084","DOI":"10.1021\/acsnano.1c02283","volume":"15","author":"D Manoharan","year":"2021","unstructured":"Manoharan D, et al. Synchronization of nanoparticle sensitization and radiosensitizing chemotherapy through cell cycle arrest achieving ultralow X-ray dose delivery to pancreatic tumors. ACS Nano. 2021;15(5):9084\u2013100.","journal-title":"ACS Nano"},{"issue":"4","key":"10092_CR139","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00535-009-0013-2","volume":"44","author":"A Masamune","year":"2009","unstructured":"Masamune A, Shimosegawa T. Signal transduction in pancreatic stellate cells. J Gastroenterol. 2009;44(4):249\u201360.","journal-title":"J Gastroenterol"},{"issue":"2","key":"10092_CR140","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.pan.2012.12.058","volume":"13","author":"A Masamune","year":"2013","unstructured":"Masamune A, Shimosegawa T. Pancreatic stellate cells\u2013multi-functional cells in the pancreas. Pancreatology. 2013;13(2):102\u20135.","journal-title":"Pancreatology"},{"issue":"11 Suppl","key":"10092_CR141","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1016\/j.cgh.2009.07.038","volume":"7","author":"A Masamune","year":"2009","unstructured":"Masamune A, et al. Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis. Clin Gastroenterol Hepatol. 2009;7(11 Suppl):S48-54.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10092_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2023.103967","volume":"185","author":"N Masoudi-Khoram","year":"2023","unstructured":"Masoudi-Khoram N, et al. Exosomes derived from cancer-associated fibroblasts mediate response to cancer therapy. Crit Rev Oncol Hematol. 2023;185:103967.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"10092_CR143","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1096\/fj.09-151639","volume":"24","author":"MG Mendez","year":"2010","unstructured":"Mendez MG, Kojima S, Goldman RD. Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition. FASEB j. 2010;24(6):1838\u201351.","journal-title":"FASEB j"},{"issue":"5","key":"10092_CR144","doi-asserted-by":"publisher","first-page":"141","DOI":"10.15698\/cst2019.05.186","volume":"3","author":"T Meng","year":"2019","unstructured":"Meng T, et al. Recent progress in the role of autophagy in neurological diseases. Cell Stress. 2019;3(5):141\u201361.","journal-title":"Cell Stress"},{"issue":"3","key":"10092_CR145","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","volume":"140","author":"N Mizushima","year":"2010","unstructured":"Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell. 2010;140(3):313\u201326.","journal-title":"Cell"},{"key":"10092_CR146","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/srep01055","volume":"3","author":"MI Molejon","year":"2013","unstructured":"Molejon MI, et al. The VMP1-Beclin 1 interaction regulates autophagy induction. Sci Rep. 2013;3:1055.","journal-title":"Sci Rep"},{"issue":"48","key":"10092_CR147","doi-asserted-by":"publisher","first-page":"47872","DOI":"10.1021\/acsomega.4c08947","volume":"9","author":"M Mortoglou","year":"2024","unstructured":"Mortoglou M, et al. MiR-210 mediated hypoxic responses in pancreatic ductal adenocarcinoma. ACS Omega. 2024;9(48):47872\u201383.","journal-title":"ACS Omega"},{"issue":"19","key":"10092_CR148","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.3390\/cancers14194582","volume":"14","author":"C Mota Reyes","year":"2022","unstructured":"Mota Reyes C, et al. Regulatory t cells in Pancreatic cancer: of mice and men. Cancers (Basel). 2022;14(19):4582.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10092_CR149","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1160181","volume":"5","author":"L M\u00fchlberg","year":"2016","unstructured":"M\u00fchlberg L, et al. MiRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancer. Oncoimmunology. 2016;5(6):e1160181.","journal-title":"Oncoimmunology"},{"issue":"10","key":"10092_CR150","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrc.2016.84","volume":"16","author":"MS Nakazawa","year":"2016","unstructured":"Nakazawa MS, Keith B, Simon MC. Oxygen availability and metabolic adaptations. Nat Rev Cancer. 2016;16(10):663\u201373.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10092_CR151","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.amjsurg.2017.03.049","volume":"214","author":"I Negoi","year":"2017","unstructured":"Negoi I, et al. Microrna-21 as a prognostic biomarker in patients with pancreatic cancer - a systematic review and meta-analysis. Am J Surg. 2017;214(3):515\u201324.","journal-title":"Am J Surg"},{"issue":"5\u20136","key":"10092_CR152","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/10799893.2019.1683863","volume":"39","author":"J Ni","year":"2019","unstructured":"Ni J, et al. Mechanism of miR-210 involved in epithelial-mesenchymal transition of pancreatic cancer cells under hypoxia. J Recept Signal Transduct Res. 2019;39(5\u20136):399\u2013406.","journal-title":"J Recept Signal Transduct Res"},{"issue":"31","key":"10092_CR153","doi-asserted-by":"publisher","first-page":"21645","DOI":"10.1074\/jbc.274.31.21645","volume":"274","author":"A Nishiyama","year":"1999","unstructured":"Nishiyama A, et al. Identification of thioredoxin-binding protein-2\/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem. 1999;274(31):21645\u201350.","journal-title":"J Biol Chem"},{"issue":"10","key":"10092_CR154","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1093\/carcin\/bgr137","volume":"32","author":"K Nishizawa","year":"2011","unstructured":"Nishizawa K, et al. Thioredoxin-interacting protein suppresses bladder carcinogenesis. Carcinogenesis. 2011;32(10):1459\u201366.","journal-title":"Carcinogenesis"},{"issue":"13","key":"10092_CR155","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1038\/s41388-017-0082-2","volume":"37","author":"Y Niu","year":"2018","unstructured":"Niu Y, et al. Mirna-646-mediated reciprocal repression between HIF-1\u03b1 and MIIP contributes to tumorigenesis of pancreatic cancer. Oncogene. 2018;37(13):1743\u201358.","journal-title":"Oncogene"},{"issue":"2","key":"10092_CR156","first-page":"1427","volume":"19","author":"K Nong","year":"2020","unstructured":"Nong K, et al. Microrna-519 inhibits hypoxia-induced tumorigenesis of pancreatic cancer by regulating immune checkpoint PD-L1. Oncol Lett. 2020;19(2):1427\u201333.","journal-title":"Oncol Lett"},{"issue":"4","key":"10092_CR157","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/ijc.32193","volume":"146","author":"M Nurmik","year":"2020","unstructured":"Nurmik M, et al. In search of definitions: cancer-associated fibroblasts and their markers. Int J Cancer. 2020;146(4):895\u2013905.","journal-title":"Int J Cancer"},{"issue":"6","key":"10092_CR158","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.3892\/or.2012.2063","volume":"28","author":"YS Oh","year":"2012","unstructured":"Oh YS, et al. Hypoxia induces CXCR4 expression and biological activity in gastric cancer cells through activation of hypoxia-inducible factor-1\u03b1. Oncol Rep. 2012;28(6):2239\u201346.","journal-title":"Oncol Rep"},{"issue":"10","key":"10092_CR159","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00262-010-0855-8","volume":"59","author":"S Ostrand-Rosenberg","year":"2010","unstructured":"Ostrand-Rosenberg S. Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity. Cancer Immunol Immunother. 2010;59(10):1593\u2013600.","journal-title":"Cancer Immunol Immunother"},{"issue":"11","key":"10092_CR160","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1080\/15476286.2019.1649585","volume":"16","author":"ZL Ou","year":"2019","unstructured":"Ou ZL, et al. Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977\/miR-153 axis. RNA Biol. 2019a;16(11):1592\u2013603.","journal-title":"RNA Biol"},{"issue":"9","key":"10092_CR161","doi-asserted-by":"publisher","first-page":"15407","DOI":"10.1002\/jcp.28188","volume":"234","author":"ZL Ou","year":"2019","unstructured":"Ou ZL, et al. Long noncoding RNA FEZF1-AS1 predicts poor prognosis and modulates pancreatic cancer cell proliferation and invasion through miR-142\/HIF-1\u03b1 and miR-133a\/EGFR upon hypoxia\/normoxia. J Cell Physiol. 2019b;234(9):15407\u201319.","journal-title":"J Cell Physiol"},{"key":"10092_CR162","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1271603","volume":"14","author":"Z Ou","year":"2023","unstructured":"Ou Z, et al. Hypoxia mediates immune escape of pancreatic cancer cells by affecting miR-1275\/AXIN2 in natural killer cells. Front Immunol. 2023;14:1271603.","journal-title":"Front Immunol"},{"issue":"19","key":"10092_CR163","doi-asserted-by":"publisher","first-page":"4748","DOI":"10.3390\/ijms20194748","volume":"20","author":"F Pacifici","year":"2019","unstructured":"Pacifici F, et al. Proposed tandem effect of physical activity and sirtuin 1 and 3 activation in regulating glucose homeostasis. Int J Mol Sci. 2019;20(19):4748.","journal-title":"Int J Mol Sci"},{"key":"10092_CR164","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.exger.2014.01.021","volume":"56","author":"K Palikaras","year":"2014","unstructured":"Palikaras K, Tavernarakis N. Mitochondrial homeostasis: the interplay between mitophagy and mitochondrial biogenesis. Exp Gerontol. 2014;56:182\u20138.","journal-title":"Exp Gerontol"},{"key":"10092_CR165","doi-asserted-by":"publisher","first-page":"3031459","DOI":"10.1155\/2016\/3031459","volume":"2016","author":"R Palmirotta","year":"2016","unstructured":"Palmirotta R, et al. Sirtuins and cancer: role in the epithelial-mesenchymal transition. Oxid Med Cell Longev. 2016;2016:3031459.","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"10092_CR166","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41416-020-01039-5","volume":"124","author":"M Piffoux","year":"2021","unstructured":"Piffoux M, Eriau E, Cassier PA. Autophagy as a therapeutic target in pancreatic cancer. Br J Cancer. 2021;124(2):333\u201344.","journal-title":"Br J Cancer"},{"issue":"6","key":"10092_CR167","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm0603-677","volume":"9","author":"CW Pugh","year":"2003","unstructured":"Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med. 2003;9(6):677\u201384.","journal-title":"Nat Med"},{"issue":"17","key":"10092_CR168","doi-asserted-by":"publisher","first-page":"8814","DOI":"10.1158\/0008-5472.CAN-05-4598","volume":"66","author":"DZ Qian","year":"2006","unstructured":"Qian DZ, et al. Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha. Cancer Res. 2006;66(17):8814\u201321.","journal-title":"Cancer Res"},{"issue":"3","key":"10092_CR169","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.bbrc.2013.12.090","volume":"443","author":"Q Qian","year":"2014","unstructured":"Qian Q, et al. VMP1 related autophagy and apoptosis in colorectal cancer cells: VMP1 regulates cell death. Biochem Biophys Res Commun. 2014;443(3):1041\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"10092_CR170","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1080\/15548627.2017.1380757","volume":"13","author":"L Qiang","year":"2017","unstructured":"Qiang L, et al. Autophagy gene ATG7 regulates ultraviolet radiation-induced inflammation and skin tumorigenesis. Autophagy. 2017;13(12):2086\u2013103.","journal-title":"Autophagy"},{"issue":"1","key":"10092_CR171","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrg.2015.10","volume":"17","author":"JJ Quinn","year":"2016","unstructured":"Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17(1):47\u201362.","journal-title":"Nat Rev Genet"},{"issue":"4","key":"10092_CR172","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1073\/pnas.1300238111","volume":"111","author":"LS Rathje","year":"2014","unstructured":"Rathje LS, et al. Oncogenes induce a vimentin filament collapse mediated by HDAC6 that is linked to cell stiffness. Proc Natl Acad Sci U S A. 2014;111(4):1515\u201320.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10092_CR173","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12943-018-0858-1","volume":"17","author":"B Ren","year":"2018","unstructured":"Ren B, et al. Tumor microenvironment participates in metastasis of pancreatic cancer. Mol Cancer. 2018;17(1):108.","journal-title":"Mol Cancer"},{"key":"10092_CR174","doi-asserted-by":"publisher","first-page":"10153","DOI":"10.1038\/ncomms10153","volume":"7","author":"L Richart","year":"2016","unstructured":"Richart L, et al. BPTF is required for c-MYC transcriptional activity and in vivo tumorigenesis. Nat Commun. 2016;7:10153.","journal-title":"Nat Commun"},{"issue":"1","key":"10092_CR175","first-page":"33","volume":"56","author":"A Riera Leal","year":"2020","unstructured":"Riera Leal A, et al. 17\u03b2-estradiol-induced mitochondrial dysfunction and Warburg effect in cervical cancer cells allow cell survival under metabolic stress. Int J Oncol. 2020;56(1):33\u201346.","journal-title":"Int J Oncol"},{"issue":"4","key":"10092_CR176","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1593\/neo.04430","volume":"7","author":"IF Robey","year":"2005","unstructured":"Robey IF, et al. Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors. Neoplasia. 2005;7(4):324\u201330.","journal-title":"Neoplasia"},{"issue":"3","key":"10092_CR177","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.drup.2011.03.001","volume":"14","author":"N Rohwer","year":"2011","unstructured":"Rohwer N, Cramer T. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways. Drug Resist Updat. 2011;14(3):191\u2013201.","journal-title":"Drug Resist Updat"},{"issue":"51","key":"10092_CR178","doi-asserted-by":"publisher","first-page":"37124","DOI":"10.1074\/jbc.M706956200","volume":"282","author":"A Ropolo","year":"2007","unstructured":"Ropolo A, et al. The pancreatitis-induced vacuole membrane protein 1 triggers autophagy in mammalian cells. J Biol Chem. 2007;282(51):37124\u201333.","journal-title":"J Biol Chem"},{"key":"10092_CR179","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00411","volume":"11","author":"A Ropolo","year":"2020","unstructured":"Ropolo A, et al. A novel E2F1-EP300-VMP1 pathway mediates gemcitabine-induced autophagy in pancreatic cancer cells carrying oncogenic KRAS. Front Endocrinol (Lausanne). 2020;11:411.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10092_CR180","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nrc2867","volume":"10","author":"BM Ryan","year":"2010","unstructured":"Ryan BM, Robles AI, Harris CC. Genetic variation in microrna networks: the implications for cancer research. Nat Rev Cancer. 2010;10(6):389\u2013402.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"10092_CR181","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1056\/NEJMra1404198","volume":"371","author":"DP Ryan","year":"2014","unstructured":"Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl J Med. 2014;371(11):1039\u201349.","journal-title":"N Engl J Med"},{"issue":"1","key":"10092_CR182","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1158\/0008-5472.CAN-09-2021","volume":"70","author":"M Sachdeva","year":"2010","unstructured":"Sachdeva M, Mo YY. Microrna-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res. 2010;70(1):378\u201387.","journal-title":"Cancer Res"},{"key":"10092_CR183","doi-asserted-by":"publisher","first-page":"1360629","DOI":"10.3389\/fimmu.2024.1360629","volume":"15","author":"H Sadozai","year":"2024","unstructured":"Sadozai H, et al. High hypoxia status in pancreatic cancer is associated with multiple hallmarks of an immunosuppressive tumor microenvironment. Front Immunol. 2024;15:1360629.","journal-title":"Front Immunol"},{"issue":"17","key":"10092_CR184","doi-asserted-by":"publisher","first-page":"6392","DOI":"10.1073\/pnas.0802047105","volume":"105","author":"C Sahlgren","year":"2008","unstructured":"Sahlgren C, et al. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci U S A. 2008;105(17):6392\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10092_CR185","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1093\/emboj\/17.9.2596","volume":"17","author":"M Saitoh","year":"1998","unstructured":"Saitoh M. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 1998;17(9):2596\u2013606.","journal-title":"EMBO J"},{"issue":"7","key":"10092_CR186","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/cas.13642","volume":"109","author":"A Sanchez Calle","year":"2018","unstructured":"Sanchez Calle A, et al. Emerging roles of long non-coding RNA in cancer. Cancer Sci. 2018;109(7):2093\u2013100.","journal-title":"Cancer Sci"},{"issue":"2","key":"10092_CR187","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1615\/CritRevOncog.2019031641","volume":"24","author":"D Sarvepalli","year":"2019","unstructured":"Sarvepalli D, et al. Gemcitabine: a review of chemoresistance in pancreatic cancer. Crit Rev Oncog. 2019;24(2):199\u2013212.","journal-title":"Crit Rev Oncog"},{"issue":"10","key":"10092_CR188","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1158\/0008-5472.CAN-22-2316","volume":"83","author":"S Schw\u00f6rer","year":"2023","unstructured":"Schw\u00f6rer S, et al. Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines. Cancer Res. 2023;83(10):1596\u2013610.","journal-title":"Cancer Res"},{"issue":"5","key":"10092_CR189","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/onc.2009.441","volume":"29","author":"GL Semenza","year":"2010","unstructured":"Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene. 2010a;29(5):625\u201334.","journal-title":"Oncogene"},{"issue":"1","key":"10092_CR190","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.gde.2009.10.009","volume":"20","author":"GL Semenza","year":"2010","unstructured":"Semenza GL. HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev. 2010b;20(1):51\u20136.","journal-title":"Curr Opin Genet Dev"},{"issue":"10","key":"10092_CR191","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1002\/(SICI)1097-0142(20000515)88:10<2239::AID-CNCR6>3.0.CO;2-V","volume":"88","author":"Y Seo","year":"2000","unstructured":"Seo Y, et al. High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer. 2000;88(10):2239\u201345.","journal-title":"Cancer"},{"issue":"6","key":"10092_CR192","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.2174\/15665240113139990055","volume":"13","author":"T Shan","year":"2013","unstructured":"Shan T, et al. \u03b22-AR-HIF-1\u03b1: a novel regulatory axis for stress-induced pancreatic tumor growth and angiogenesis. Curr Mol Med. 2013;13(6):1023\u201334.","journal-title":"Curr Mol Med"},{"key":"10092_CR193","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.canlet.2020.10.011","volume":"496","author":"M Shi","year":"2021","unstructured":"Shi M, et al. APC(CDC20)-mediated degradation of PHD3 stabilizes HIF-1a and promotes tumorigenesis in hepatocellular carcinoma. Cancer Lett. 2021;496:144\u201355.","journal-title":"Cancer Lett"},{"issue":"5","key":"10092_CR194","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.bbamcr.2007.10.012","volume":"1783","author":"D Shin","year":"2008","unstructured":"Shin D, et al. VDUP1 mediates nuclear export of HIF1alpha via CRM1-dependent pathway. Biochim Biophys Acta. 2008;1783(5):838\u201348.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10092_CR195","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ccell.2017.06.004","volume":"32","author":"SK Shukla","year":"2017","unstructured":"Shukla SK, et al. MUC1 and HIF-1alpha signaling crosstalk induces anabolic glucose metabolism to impart gemcitabine resistance to pancreatic cancer. Cancer Cell. 2017;32(1):71-87.e7.","journal-title":"Cancer Cell"},{"key":"10092_CR196","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jconrel.2014.04.021","volume":"190","author":"A Singh","year":"2014","unstructured":"Singh A, et al. Macrophage-targeted delivery systems for nucleic acid therapy of inflammatory diseases. J Control Release. 2014;190:515\u201330.","journal-title":"J Control Release"},{"key":"10092_CR197","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174209","author":"N Skorupan","year":"2022","unstructured":"Skorupan N, et al. Clinical strategies targeting the tumor microenvironment of pancreatic ductal adenocarcinoma. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14174209.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10092_CR198","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","volume":"179","author":"FJ Slack","year":"2019","unstructured":"Slack FJ, Chinnaiyan AM. The role of non-coding RNAs in oncology. Cell. 2019;179(5):1033\u201355.","journal-title":"Cell"},{"issue":"11","key":"10092_CR199","doi-asserted-by":"publisher","first-page":"11319","DOI":"10.1007\/s13277-014-2452-5","volume":"35","author":"Z Song","year":"2014","unstructured":"Song Z, et al. The clinical significance and regulation mechanism of hypoxia-inducible factor-1 and miR-191 expression in pancreatic cancer. Tumour Biol. 2014;35(11):11319\u201328.","journal-title":"Tumour Biol"},{"issue":"6","key":"10092_CR200","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1089\/ars.2011.4137","volume":"16","author":"ON Spindel","year":"2012","unstructured":"Spindel ON, World C, Berk BC. Thioredoxin interacting protein: redox dependent and independent regulatory mechanisms. Antioxid Redox Signal. 2012;16(6):587\u201396.","journal-title":"Antioxid Redox Signal"},{"issue":"11","key":"10092_CR201","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1158\/0008-5472.CAN-11-1433","volume":"73","author":"TR Spivak-Kroizman","year":"2013","unstructured":"Spivak-Kroizman TR, et al. Hypoxia triggers hedgehog-mediated tumor-stromal interactions in pancreatic cancer. Cancer Res. 2013;73(11):3235\u201347.","journal-title":"Cancer Res"},{"issue":"11","key":"10092_CR202","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1136\/gutjnl-2013-306271","volume":"63","author":"IM Stromnes","year":"2014","unstructured":"Stromnes IM, et al. Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity. Gut. 2014;63(11):1769\u201381.","journal-title":"Gut"},{"issue":"4","key":"10092_CR203","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.cmet.2012.09.006","volume":"16","author":"X Su","year":"2012","unstructured":"Su X, et al. TAp63 is a master transcriptional regulator of lipid and glucose metabolism. Cell Metab. 2012;16(4):511\u201325.","journal-title":"Cell Metab"},{"issue":"17","key":"10092_CR204","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1038\/onc.2016.388","volume":"36","author":"X Su","year":"2017","unstructured":"Su X, et al. TAp63 suppresses mammary tumorigenesis through regulation of the hippo pathway. Oncogene. 2017;36(17):2377\u201393.","journal-title":"Oncogene"},{"issue":"2","key":"10092_CR205","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3892\/ol.2015.3344","volume":"10","author":"JS Sun","year":"2015","unstructured":"Sun JS, et al. Hypoxia promotes C-X-C chemokine receptor type 4 expression through microRNA-150 in pancreatic cancer cells. Oncol Lett. 2015;10(2):835\u201340.","journal-title":"Oncol Lett"},{"issue":"1","key":"10092_CR206","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/path.4823","volume":"241","author":"Y Sun","year":"2017","unstructured":"Sun Y, et al. MIIP haploinsufficiency induces chromosomal instability and promotes tumour progression in colorectal cancer. J Pathol. 2017;241(1):67\u201379.","journal-title":"J Pathol"},{"key":"10092_CR207","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S211535","author":"J Sun","year":"2019","unstructured":"Sun J, et al. Downregulation of miR-21 inhibits the malignant phenotype of pancreatic cancer cells by targeting VHL. OncoTargets Ther. 2019a. https:\/\/doi.org\/10.2147\/OTT.S211535.","journal-title":"OncoTargets Ther"},{"key":"10092_CR208","doi-asserted-by":"publisher","first-page":"7215","DOI":"10.2147\/OTT.S211535","volume":"12","author":"J Sun","year":"2019","unstructured":"Sun J, et al. Downregulation of miR-21 inhibits the malignant phenotype of pancreatic cancer cells by targeting VHL. Onco Targets Ther. 2019b;12:7215\u201326.","journal-title":"Onco Targets Ther"},{"issue":"9","key":"10092_CR209","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.7150\/jca.37959","volume":"11","author":"J Sun","year":"2020","unstructured":"Sun J, et al. Upregulation of LncRNA PVT1 facilitates pancreatic ductal adenocarcinoma cell progression and glycolysis by regulating MiR-519d-3p and HIF-1A. J Cancer. 2020;11(9):2572\u20139.","journal-title":"J Cancer"},{"issue":"13","key":"10092_CR210","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.7150\/ijbs.61795","volume":"17","author":"T Sun","year":"2021","unstructured":"Sun T, et al. Autophagy-mediated negative feedback attenuates the oncogenic activity of YAP in pancreatic cancer. Int J Biol Sci. 2021;17(13):3634\u201345.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"10092_CR211","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.bbrc.2013.06.097","volume":"437","author":"T Takikawa","year":"2013","unstructured":"Takikawa T, et al. MiR-210 regulates the interaction between pancreatic cancer cells and stellate cells. Biochem Biophys Res Commun. 2013;437(3):433\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10092_CR212","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MPA.0000000000000722","volume":"46","author":"T Takikawa","year":"2017","unstructured":"Takikawa T, et al. Exosomes derived from pancreatic stellate cells: microrna signature and effects on pancreatic cancer cells. Pancreas. 2017;46(1):19\u201327.","journal-title":"Pancreas"},{"issue":"5","key":"10092_CR213","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1158\/1078-0432.CCR-05-1981","volume":"12","author":"IY Tam","year":"2006","unstructured":"Tam IY, et al. Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features. Clin Cancer Res. 2006;12(5):1647\u201353.","journal-title":"Clin Cancer Res"},{"issue":"7483","key":"10092_CR214","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344\u201352.","journal-title":"Nature"},{"issue":"5","key":"10092_CR215","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, et al. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871\u201390.","journal-title":"Cell"},{"issue":"7","key":"10092_CR216","doi-asserted-by":"publisher","first-page":"11071","DOI":"10.18632\/oncotarget.14360","volume":"8","author":"S Tian","year":"2017","unstructured":"Tian S, et al. miR-138-5p suppresses autophagy in pancreatic cancer by targeting SIRT1. Oncotarget. 2017;8(7):11071\u201382.","journal-title":"Oncotarget"},{"issue":"1","key":"10092_CR217","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12935-023-02925-7","volume":"23","author":"F Tolue Ghasaban","year":"2023","unstructured":"Tolue Ghasaban F, et al. Micrornas as the critical regulators of autophagy-mediated cisplatin response in tumor cells. Cancer Cell Int. 2023;23(1):80.","journal-title":"Cancer Cell Int"},{"key":"10092_CR218","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20225625","author":"YT Tsai","year":"2019","unstructured":"Tsai YT, et al. ANGPTL4 induces TMZ resistance of glioblastoma by promoting cancer stemness enrichment via the EGFR\/AKT\/4E-BP1 cascade. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20225625.","journal-title":"Int J Mol Sci"},{"issue":"15","key":"10092_CR219","doi-asserted-by":"publisher","first-page":"14871","DOI":"10.1074\/jbc.M400461200","volume":"279","author":"T Uchida","year":"2004","unstructured":"Uchida T, et al. Prolonged hypoxia differentially regulates hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression in lung epithelial cells: implication of natural antisense HIF-1alpha. J Biol Chem. 2004;279(15):14871\u20138.","journal-title":"J Biol Chem"},{"issue":"Pt 2","key":"10092_CR220","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1113\/jphysiol.2005.090985","volume":"568","author":"V Valiunas","year":"2005","unstructured":"Valiunas V, et al. Connexin-specific cell-to-cell transfer of short interfering RNA by gap junctions. J Physiol. 2005;568(Pt 2):459\u201368.","journal-title":"J Physiol"},{"issue":"13","key":"10092_CR221","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1200\/JCO.2008.20.0238","volume":"27","author":"E Van Cutsem","year":"2009","unstructured":"Van Cutsem E, et al. Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. J Clin Oncol. 2009;27(13):2231\u20137.","journal-title":"J Clin Oncol"},{"issue":"9791","key":"10092_CR222","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","volume":"378","author":"A Vincent","year":"2011","unstructured":"Vincent A, et al. Pancreatic cancer. Lancet. 2011;378(9791):607\u201320.","journal-title":"Lancet"},{"issue":"10","key":"10092_CR223","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.celrep.2017.05.041","volume":"19","author":"AN Waldhart","year":"2017","unstructured":"Waldhart AN, et al. Phosphorylation of TXNIP by AKT mediates acute influx of glucose in response to insulin. Cell Rep. 2017;19(10):2005\u201313.","journal-title":"Cell Rep"},{"issue":"6","key":"10092_CR224","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","volume":"43","author":"KC Wang","year":"2011","unstructured":"Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43(6):904\u201314.","journal-title":"Mol Cell"},{"key":"10092_CR225","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107990","volume":"100","author":"S Wang","year":"2021","unstructured":"Wang S, Gao Y. Pancreatic cancer cell-derived microrna-155-5p-containing extracellular vesicles promote immune evasion by triggering EHF-dependent activation of Akt\/NF-\u03baB signaling pathway. Int Immunopharmacol. 2021;100:107990.","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"10092_CR226","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1158\/1940-6207.CAPR-09-0094","volume":"2","author":"J Wang","year":"2009","unstructured":"Wang J, et al. Micrornas in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res (Phila). 2009;2(9):807\u201313.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"47","key":"10092_CR227","doi-asserted-by":"publisher","first-page":"41095","DOI":"10.1074\/jbc.M111.296806","volume":"286","author":"Y Wang","year":"2011","unstructured":"Wang Y, et al. Angiomotin-like2 gene (amotl2) is required for migration and proliferation of endothelial cells during angiogenesis. J Biol Chem. 2011a;286(47):41095\u2013104.","journal-title":"J Biol Chem"},{"issue":"1","key":"10092_CR228","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2174\/138920311795659434","volume":"12","author":"Y Wang","year":"2011","unstructured":"Wang Y, Wen J, Zhang W. MIIP, a cytoskeleton regulator that blocks cell migration and invasion, delays mitosis, and suppresses tumorogenesis. Curr Protein Pept Sci. 2011b;12(1):68\u201373.","journal-title":"Curr Protein Pept Sci"},{"issue":"3","key":"10092_CR229","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.molonc.2012.10.011","volume":"7","author":"P Wang","year":"2013","unstructured":"Wang P, et al. The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL. Mol Oncol. 2013;7(3):334\u201345.","journal-title":"Mol Oncol"},{"issue":"2","key":"10092_CR230","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1158\/0008-5472.CAN-14-2819","volume":"75","author":"J Wang","year":"2015","unstructured":"Wang J, et al. Novel mechanism of macrophage-mediated metastasis revealed in a zebrafish model of tumor development. Cancer Res. 2015;75(2):306\u201315.","journal-title":"Cancer Res"},{"issue":"12","key":"10092_CR231","doi-asserted-by":"publisher","first-page":"13717","DOI":"10.18632\/oncotarget.7263","volume":"7","author":"X Wang","year":"2016","unstructured":"Wang X, et al. Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes. Oncotarget. 2016a;7(12):13717\u201329.","journal-title":"Oncotarget"},{"issue":"1","key":"10092_CR232","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13045-016-0342-6","volume":"9","author":"Y Wang","year":"2016","unstructured":"Wang Y, et al. MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis. J Hematol Oncol. 2016b;9(1):112.","journal-title":"J Hematol Oncol"},{"issue":"45","key":"10092_CR233","doi-asserted-by":"publisher","first-page":"6235","DOI":"10.1038\/onc.2017.217","volume":"36","author":"J Wang","year":"2017","unstructured":"Wang J, et al. BIN1 reverses PD-L1-mediated immune escape by inactivating the c-MYC and EGFR\/MAPK signaling pathways in non-small cell lung cancer. Oncogene. 2017;36(45):6235\u201343.","journal-title":"Oncogene"},{"issue":"16","key":"10092_CR234","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1158\/0008-5472.CAN-17-3841","volume":"78","author":"X Wang","year":"2018","unstructured":"Wang X, et al. Hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN\/PI3K\u03b3 to promote pancreatic cancer metastasis. Cancer Res. 2018;78(16):4586\u201398.","journal-title":"Cancer Res"},{"issue":"6","key":"10092_CR235","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1038\/s41418-019-0458-7","volume":"27","author":"X Wang","year":"2020","unstructured":"Wang X, et al. The deubiquitinase USP10 regulates KLF4 stability and suppresses lung tumorigenesis. Cell Death Differ. 2020a;27(6):1747\u201364.","journal-title":"Cell Death Differ"},{"issue":"1","key":"10092_CR236","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2019.111713","volume":"386","author":"XX Wang","year":"2020","unstructured":"Wang XX, et al. TWIST1 transcriptionally regulates glycolytic genes to promote the Warburg metabolism in pancreatic cancer. Exp Cell Res. 2020b;386(1):111713.","journal-title":"Exp Cell Res"},{"issue":"7","key":"10092_CR237","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22782","volume":"35","author":"P Wang","year":"2021","unstructured":"Wang P, et al. Thioredoxin-interacting protein is a favored target of miR-125b, promoting metastasis and progression of pancreatic cancer via the HIF1\u03b1 pathway. J Biochem Mol Toxicol. 2021a;35(7):e22782.","journal-title":"J Biochem Mol Toxicol"},{"issue":"1","key":"10092_CR238","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12943-020-01298-z","volume":"20","author":"S Wang","year":"2021","unstructured":"Wang S, et al. Circular rnas in body fluids as cancer biomarkers: the new frontier of liquid biopsies. Mol Cancer. 2021b;20(1):13.","journal-title":"Mol Cancer"},{"key":"10092_CR239","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-024-01091-z","author":"L Wang","year":"2024","unstructured":"Wang L, et al. Hypoxia-challenged pancreatic adenocarcinoma cell-derived exosomal circR3HCC1L drives tumor growth via upregulating PKM2 through sequestering miR-873-5p. Mol Biotechnol. 2024. https:\/\/doi.org\/10.1007\/s12033-024-01091-z.","journal-title":"Mol Biotechnol"},{"issue":"7851","key":"10092_CR240","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","volume":"591","author":"MJ Watson","year":"2021","unstructured":"Watson MJ, et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature. 2021;591(7851):645\u201351.","journal-title":"Nature"},{"key":"10092_CR241","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2022.101851","volume":"77","author":"X Wei","year":"2022","unstructured":"Wei X, et al. VMP1 promotes exosome secretion and enhances 5-FU resistance in colon cancer cells. Tissue Cell. 2022;77:101851.","journal-title":"Tissue Cell"},{"issue":"1","key":"10092_CR242","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41420-023-01319-y","volume":"9","author":"L Wei","year":"2023","unstructured":"Wei L, et al. Verteporfin reverses progestin resistance through YAP\/TAZ-PI3K-Akt pathway in endometrial carcinoma. Cell Death Discov. 2023;9(1):30.","journal-title":"Cell Death Discov"},{"issue":"17","key":"10092_CR243","first-page":"5089","volume":"62","author":"SJ Welsh","year":"2002","unstructured":"Welsh SJ, et al. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Cancer Res. 2002;62(17):5089\u201395.","journal-title":"Cancer Res"},{"key":"10092_CR244","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.smim.2017.12.003","volume":"35","author":"TL Whiteside","year":"2018","unstructured":"Whiteside TL. Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment. Semin Immunol. 2018;35:69\u201379.","journal-title":"Semin Immunol"},{"key":"10092_CR245","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065113","author":"J Wnuk","year":"2023","unstructured":"Wnuk J, Strzelczyk JK, Gisterek I. Clinical value of circulating miRNA in diagnosis, prognosis, screening and monitoring therapy of pancreatic ductal adenocarcinoma-a review of the literature. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24065113.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10092_CR246","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bbrc.2013.02.070","volume":"433","author":"RW Wong","year":"2013","unstructured":"Wong RW, Hagen T. Mechanistic target of rapamycin (mTOR) dependent regulation of thioredoxin interacting protein (TXNIP) transcription in hypoxia. Biochem Biophys Res Commun. 2013;433(1):40\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10092_CR247","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","volume":"163","author":"LD Wood","year":"2022","unstructured":"Wood LD, et al. Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment. Gastroenterology. 2022;163(2):386-402.e1.","journal-title":"Gastroenterology"},{"issue":"1","key":"10092_CR248","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.redox.2013.04.006","volume":"1","author":"CM Woolston","year":"2013","unstructured":"Woolston CM, et al. Thioredoxin interacting protein and its association with clinical outcome in gastro-oesophageal adenocarcinoma. Redox Biol. 2013;1(1):285\u201391.","journal-title":"Redox Biol"},{"issue":"3","key":"10092_CR249","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1159\/000494477","volume":"50","author":"DH Wu","year":"2018","unstructured":"Wu DH, et al. Mir-124 suppresses pancreatic ductal adenocarcinoma growth by regulating monocarboxylate transporter 1-mediated cancer lactate metabolism. Cell Physiol Biochem. 2018;50(3):924\u201335.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"10092_CR250","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12943-020-01238-x","volume":"19","author":"SY Wu","year":"2020","unstructured":"Wu SY, et al. Natural killer cells in cancer biology and therapy. Mol Cancer. 2020;19(1):120.","journal-title":"Mol Cancer"},{"issue":"1","key":"10092_CR251","first-page":"7752277","volume":"2022","author":"G Wu","year":"2022","unstructured":"Wu G, Ding X, Quan G, Xiong J, Li Q, Li Z, et al. Hypoxia-induced miR-210 promotes endothelial cell permeability and angiogenesis via exosomes in pancreatic ductal adenocarcinoma. Biochem Res Int. 2022;2022(1):7752277.","journal-title":"Biochem Res Int"},{"key":"10092_CR252","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd6764","author":"X Xin","year":"2020","unstructured":"Xin X, et al. Redox-responsive nanoplatform for codelivery of miR-519c and gemcitabine for pancreatic cancer therapy. Sci Adv. 2020. https:\/\/doi.org\/10.1126\/sciadv.abd6764.","journal-title":"Sci Adv"},{"issue":"2","key":"10092_CR253","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1158\/0008-5472.613.65.2","volume":"65","author":"RH Xu","year":"2005","unstructured":"Xu RH, et al. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res. 2005;65(2):613\u201321.","journal-title":"Cancer Res"},{"issue":"7","key":"10092_CR254","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.18632\/oncotarget.3069","volume":"6","author":"Q Xu","year":"2015","unstructured":"Xu Q, et al. Stromal-derived factor-1\u03b1\/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreatic cancer. Oncotarget. 2015;6(7):4717\u201332.","journal-title":"Oncotarget"},{"issue":"7","key":"10092_CR255","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1161\/CIRCRESAHA.119.316444","volume":"126","author":"N Xu","year":"2020","unstructured":"Xu N, et al. Ube2v1 positively regulates protein aggregation by modulating ubiquitin proteasome system performance partially through K63 ubiquitination. Circ Res. 2020;126(7):907\u201322.","journal-title":"Circ Res"},{"issue":"22","key":"10092_CR256","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1158\/0008-5472.CAN-21-0281","volume":"81","author":"F Xu","year":"2021","unstructured":"Xu F, et al. LncRNA HIF1A-AS1 promotes gemcitabine resistance of pancreatic cancer by enhancing glycolysis through modulating the AKT\/YB1\/HIF1\u03b1 pathway. Cancer Res. 2021;81(22):5678\u201391.","journal-title":"Cancer Res"},{"issue":"7","key":"10092_CR257","doi-asserted-by":"publisher","first-page":"6901","DOI":"10.1007\/s13277-014-1925-x","volume":"35","author":"M Xue","year":"2014","unstructured":"Xue M, et al. Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1\u03b1-targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration, and invasion. Tumour Biol. 2014;35(7):6901\u201312.","journal-title":"Tumour Biol"},{"issue":"5","key":"10092_CR258","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.surg.2013.05.004","volume":"154","author":"S Yamada","year":"2013","unstructured":"Yamada S, et al. Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer. Surgery. 2013;154(5):946\u201354.","journal-title":"Surgery"},{"key":"10092_CR259","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2020.04.018","volume":"484","author":"A Yamasaki","year":"2020","unstructured":"Yamasaki A, Yanai K, Onishi H. Hypoxia and pancreatic ductal adenocarcinoma. Cancer Lett. 2020;484:9\u201315.","journal-title":"Cancer Lett"},{"issue":"3","key":"10092_CR260","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ncb1691","volume":"10","author":"MH Yang","year":"2008","unstructured":"Yang MH, et al. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol. 2008;10(3):295\u2013305.","journal-title":"Nat Cell Biol"},{"key":"10092_CR261","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3389\/fonc.2019.00356","volume":"9","author":"X Yang","year":"2019","unstructured":"Yang X, et al. Role of exosomes in crosstalk between cancer-associated fibroblasts and cancer cells. Front Oncol. 2019;9:356.","journal-title":"Front Oncol"},{"issue":"1 Pt 1","key":"10092_CR262","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ygeno.2020.12.013","volume":"113","author":"X Yang","year":"2021","unstructured":"Yang X, et al. Circrnas as promising biomarker in diagnostic and prognostic of lung cancer: an updated meta-analysis. Genomics. 2021a;113(1 Pt 1):387\u201397.","journal-title":"Genomics"},{"issue":"1","key":"10092_CR263","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12943-020-01300-8","volume":"20","author":"X Yang","year":"2021","unstructured":"Yang X, et al. Expression profiles, biological functions and clinical significance of circRNAs in bladder cancer. Mol Cancer. 2021b;20(1):4.","journal-title":"Mol Cancer"},{"issue":"1","key":"10092_CR264","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/s12935-022-02741-5","volume":"22","author":"J Yao","year":"2022","unstructured":"Yao J, et al. Exosomal LINC00460\/miR-503-5p\/ANLN positive feedback loop aggravates pancreatic cancer progression through regulating T cell-mediated cytotoxicity and PD-1 checkpoint. Cancer Cell Int. 2022;22(1):390.","journal-title":"Cancer Cell Int"},{"issue":"11","key":"10092_CR265","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1172\/JCI87252","volume":"126","author":"M Yin","year":"2016","unstructured":"Yin M, et al. Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer. J Clin Invest. 2016;126(11):4157\u201373.","journal-title":"J Clin Invest"},{"issue":"7","key":"10092_CR266","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1158\/1078-0432.CCR-03-0488","volume":"10","author":"K Yokoi","year":"2004","unstructured":"Yokoi K, Fidler IJ. Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine. Clin Cancer Res. 2004;10(7):2299\u2013306.","journal-title":"Clin Cancer Res"},{"key":"10092_CR267","first-page":"6495867","volume":"2017","author":"Q Yu","year":"2017","unstructured":"Yu Q, et al. Evaluation of Plasma MicroRNAs as diagnostic and prognostic biomarkers in pancreatic adenocarcinoma: miR-196a and miR-210 could be negative and positive prognostic markers. Respectively Biomed Res Int. 2017;2017:6495867.","journal-title":"Respectively Biomed Res Int"},{"issue":"3","key":"10092_CR268","first-page":"2359","volume":"17","author":"H Yue","year":"2019","unstructured":"Yue H, Liu L, Song Z. MiR-212 regulated by HIF-1\u03b1 promotes the progression of pancreatic cancer. Exp Ther Med. 2019;17(3):2359\u201365.","journal-title":"Exp Ther Med"},{"key":"10092_CR269","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fonc.2020.00159","volume":"10","author":"K Zahra","year":"2020","unstructured":"Zahra K, et al. Pyruvate kinase M2 and cancer: the role of PKM2 in promoting tumorigenesis. Front Oncol. 2020;10:159.","journal-title":"Front Oncol"},{"issue":"6","key":"10092_CR270","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1172\/JCI36183","volume":"119","author":"M Zeisberg","year":"2009","unstructured":"Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest. 2009;119(6):1429\u201337.","journal-title":"J Clin Invest"},{"issue":"36","key":"10092_CR271","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1038\/s41388-021-01960-w","volume":"40","author":"Z Zeng","year":"2021","unstructured":"Zeng Z, et al. Hypoxic exosomal HIF-1\u03b1-stabilizing circZNF91 promotes chemoresistance of normoxic pancreatic cancer cells via enhancing glycolysis. Oncogene. 2021;40(36):5505\u201317.","journal-title":"Oncogene"},{"issue":"2","key":"10092_CR272","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12419","volume":"63","author":"M Zhai","year":"2017","unstructured":"Zhai M, et al. Melatonin ameliorates myocardial ischemia reperfusion injury through SIRT 3-dependent regulation of oxidative stress and apoptosis. J Pineal Res. 2017;63(2):e12419.","journal-title":"J Pineal Res"},{"issue":"2","key":"10092_CR273","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1158\/0008-5472.CAN-09-0448","volume":"70","author":"D Zhang","year":"2010","unstructured":"Zhang D, et al. JNK1 mediates degradation HIF-1alpha by a VHL-independent mechanism that involves the chaperones Hsp90\/Hsp70. Cancer Res. 2010;70(2):813\u201323.","journal-title":"Cancer Res"},{"issue":"1","key":"10092_CR274","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12943-017-0689-5","volume":"16","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, et al. Hypoxia-inducible factor-2\u03b1 promotes tumor progression and has crosstalk with Wnt\/\u03b2-catenin signaling in pancreatic cancer. Mol Cancer. 2017;16(1):119.","journal-title":"Mol Cancer"},{"key":"10092_CR275","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.biopha.2018.09.136","volume":"108","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, et al. Role of angiogenesis in pancreatic cancer biology and therapy. Biomed Pharmacother. 2018;108:1135\u201340.","journal-title":"Biomed Pharmacother"},{"issue":"19","key":"10092_CR276","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.3748\/wjg.v26.i19.2349","volume":"26","author":"KD Zhang","year":"2020","unstructured":"Zhang KD, et al. MiR-301a transcriptionally activated by HIF-2\u03b1 promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer. World J Gastroenterol. 2020a;26(19):2349\u201373.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10092_CR277","first-page":"1098","volume":"24","author":"GF Zhang","year":"2020","unstructured":"Zhang GF, et al. MiR-19 enhances pancreatic cancer progression by targeting PTEN through PI3K\/AKT signaling pathway. Eur Rev Med Pharmacol Sci. 2020b;24(3):1098\u2013107.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10092_CR278","doi-asserted-by":"publisher","DOI":"10.3892\/or.2021.8085","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Ma H, Chen C. Long non-coding RNA PCED1B-AS1 promotes pancreatic ductal adenocarcinoma progression by regulating the miR-411-3p\/HIF-1\u03b1 axis. Oncol Rep. 2021. https:\/\/doi.org\/10.3892\/or.2021.8085.","journal-title":"Oncol Rep"},{"issue":"10","key":"10092_CR279","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.7150\/ijms.87833","volume":"20","author":"R Zhang","year":"2023","unstructured":"Zhang R, et al. Hypoxia-induced long non-coding RNA LINC00460 promotes p53 mediated proliferation and metastasis of pancreatic cancer by regulating the miR-4689\/UBE2V1 axis and sequestering USP10. Int J Med Sci. 2023;20(10):1339\u201357.","journal-title":"Int J Med Sci"},{"issue":"1","key":"10092_CR280","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-57769-6","volume":"14","author":"P Zhang","year":"2024","unstructured":"Zhang P, et al. NNT-AS1 in CAFs-derived exosomes promotes progression and glucose metabolism through miR-889-3p\/HIF-1\u03b1 in pancreatic adenocarcinoma. Sci Rep. 2024;14(1):6979.","journal-title":"Sci Rep"},{"issue":"2","key":"10092_CR281","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/15548627.2017.1415591","volume":"14","author":"YG Zhao","year":"2018","unstructured":"Zhao YG, Zhang H. The ER-localized autophagy protein EPG-3\/VMP1 regulates ER contacts with other organelles by modulating ATP2A\/SERCA activity. Autophagy. 2018;14(2):362\u20133.","journal-title":"Autophagy"},{"issue":"14","key":"10092_CR282","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1101\/gad.1664408","volume":"22","author":"B Zhao","year":"2008","unstructured":"Zhao B, et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 2008;22(14):1962\u201371.","journal-title":"Genes Dev"},{"issue":"1","key":"10092_CR283","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41392-020-0132-z","volume":"5","author":"J Zhao","year":"2020","unstructured":"Zhao J, et al. The HIF-1A\/miR-17-5p\/PDCD4 axis contributes to the tumor growth and metastasis of gastric cancer. Signal Transduct Target Ther. 2020;5(1):46.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"10092_CR284","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1002\/kjm2.12590","volume":"38","author":"B Zhou","year":"2022","unstructured":"Zhou B, et al. Cancer-associated fibroblast-secreted miR-421 promotes pancreatic cancer by regulating the SIRT3\/H3K9Ac\/HIF-1\u03b1 axis. Kaohsiung J Med Sci. 2022;38(11):1080\u201392.","journal-title":"Kaohsiung J Med Sci"},{"issue":"9","key":"10092_CR285","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1158\/1535-7163.MCT-15-0877","volume":"15","author":"S Zhu","year":"2016","unstructured":"Zhu S, et al. Mir-548an, transcriptionally downregulated by HIF1\u03b1\/HDAC1, suppresses tumorigenesis of pancreatic cancer by targeting vimentin expression. Mol Cancer Ther. 2016;15(9):2209\u201319.","journal-title":"Mol Cancer Ther"},{"issue":"12","key":"10092_CR286","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1111\/jcmm.13264","volume":"21","author":"Y Zhu","year":"2017","unstructured":"Zhu Y, et al. A positive feedback loop promotes HIF-1\u03b1 stability through miR-210-mediated suppression of RUNX3 in paraquat-induced EMT. J Cell Mol Med. 2017;21(12):3529\u201339.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"10092_CR287","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1159\/000492309","volume":"48","author":"G Zhu","year":"2018","unstructured":"Zhu G, et al. Microrna-224 promotes pancreatic cancer cell proliferation and migration by targeting the TXNIP-mediated HIF1\u03b1 pathway. Cell Physiol Biochem. 2018;48(4):1735\u201346.","journal-title":"Cell Physiol Biochem"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-025-10092-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10565-025-10092-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-025-10092-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:07:07Z","timestamp":1761880027000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10565-025-10092-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":287,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10092"],"URL":"https:\/\/doi.org\/10.1007\/s10565-025-10092-w","relation":{},"ISSN":["1573-6822"],"issn-type":[{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The manuscript is approved by all authors for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"146"}}